department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

News

when

Latest
Archive

by source

All Sources
Sources Page

Companies

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

Calendar

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

made by humans and a good dog

home
jobs
news
cal
search

calendar

11 catalysts · 11 phase 2 completion · 5 phase 2 initiation · 5 phase 1 initiation · 5 filing · 4 phase 0 trial completion · 4 phase 3 initiation

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

show past →

sort

soonest latest type sponsor alpha

type: phase 2 completion×TA: ophthalmology×TA: dermatology×clear all

type

phase 2 completion11
phase 2 initiation5
phase 1 initiation5
filing5
phase 0 trial completion4
phase 3 initiation4

phase 1 2 completion3

constraining patent expiry europe2

phase 1 completion2

phase 2 3 initiation1

therapy area

Oncology36
Immunology11
Women's Health10
Cardiology10
Infectious Disease8
Dermatology7
Pulmonology6
Ophthalmology4
Pain4

Week of Apr 20, 2026

›Apr 24, 2026phase 2 completion74d agoKothiwal Dental College and Research Centre — platelet rich plasma (Phase II Trial Completion)platelet rich plasma

Therapy area: Dermatology. Indication: Androgenic Alopecia

full page →platelet rich plasma →source: globaldata

›Apr 26, 2026phase 2 completion72d agoCentral Council for Research in Unani Medicine — unani medicine (Phase II Trial Completion)unani medicine

Therapy area: Ophthalmology. Indication: Asthenopia (Eye Strain), Keratoconjunctivitis Sicca (Dry Eye), Unspecified Ophthalmological Disorders

full page →unani medicine →source: globaldata

›Apr 26, 2026phase 2 completion72d agoChongqing Jinsaixing Medical Technology Co Ltd — Neauvia Intense (Phase II Trial Completion)Neauvia Intense

Therapy area: Dermatology. Indication: Wrinkles

full page →Neauvia Intense →source: globaldata

Week of Apr 27, 2026

›Apr 27, 2026phase 2 completion71d agoSMBT Ayurved College and Hospital — ayurvedic medicine (Phase II Trial Completion)ayurvedic medicine

Therapy area: Ophthalmology. Indication: Keratoconjunctivitis Sicca (Dry Eye)

full page →ayurvedic medicine →source: globaldata

›Apr 29, 2026phase 2 completion

69d ago

Massachusetts Eye and Ear Infirmary — N-acetylcysteine (Phase II Trial Completion)N-acetylcysteine

Therapy area: Ophthalmology. Indication: Cataract, Fuchs Endothelial Corneal Dystrophy (FECD)

full page →N-acetylcysteine →source: globaldata

›Apr 29, 2026phase 2 completion69d agoBangalore Medical College and Research Institute — dinoprostone (Phase II Trial Completion)dinoprostone ER

Therapy area: Dermatology. Indication: Vitiligo

full page →dinoprostone ER →source: globaldata

›Apr 30, 2026phase 2 completion68d agoVaidya Yagya Dutt Sharma Ayurvedic P. G. Mahavidhyalaya — ayurvedic medicine (Phase II Trial Completion)ayurvedic medicine

Therapy area: Dermatology. Indication: Burns

full page →ayurvedic medicine →source: globaldata

›Apr 30, 2026phase 2 completion68d agoShenzhen Eye Hospital — umbilical cord mesenchymal stem cells derived apoptotic vesicles (Phase II Trial Completion)umbilical cord mesenchymal stem cells derived apoptotic vesicles

Therapy area: Ophthalmology. Indication: Keratoconjunctivitis Sicca (Dry Eye)

full page →umbilical cord mesenchymal stem cells derived apoptotic vesicles →source: globaldata

›Apr 30, 2026phase 2 completion68d agoNigde Omer Halisdemir University — ozonated oil (Phase II Trial Completion)ozonated oil

Therapy area: Dermatology, Gastrointestinal, Immunology. Indication: Inflammation, Inguinal Hernia, Wounds

full page →ozonated oil →source: globaldata

›Apr 30, 2026phase 2 completion68d agoJetema Co Ltd — JTM-102 (Phase II Trial Completion)JTM-102

Therapy area: Dermatology. Indication: Unspecified Dermatological Disorders

full page →JTM-102 →source: globaldata

›Apr 30, 2026phase 2 completion68d agoChinese Academy of Medical Sciences Plastic Surgery Hospital — recombinant type III humanized collagen (Phase II Trial Completion)recombinant type III humanized collagen

Therapy area: Dermatology. Indication: Crow Feet, Unspecified Dermatological Disorders, Wrinkles, Xerosis (Dry Skin)

full page →recombinant type III humanized collagen →source: globaldata